Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PIIIthis companyP3 Health Partners Inc.	$4.18	-0.08×	-0.07×	0.01×	-1.49×	-13900.3%	-9.9%	-18.5%	-10.1%	95.3%	-172.8%	-799.7%	-1.84×	-1.43×	-4.91×	0.24×	0.0%	3	-0.29	2	C
HYPDHyperion DeFi, Inc.	$2.57	-0.38×	0.43×	21.88×	-0.45×	-153.6%	62.7%	-2333.4%	-5570.6%	-110.4%	-38.3%	-83.0%	0.21×	-0.05×	-12.18×	2.68×	5.0%	6	-0.75	3	B+
IBIOiBio, Inc.	$0.79	-5.47×	2.12×	1,821.05×	-4×	-38.6%	100.0%	-35141.0%	-33044.0%	-38.6%	-40.0%	-13.1%	0.03×	1.7×	-663.04×	7.85×	0.0%	2	-3.05	2	C+
INTSIntensity Therapeutics, Inc.	$2.93	-1.2×	1.17×	0×	-0.18×	143.3%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-66.3%	0.01×	1.02×	0×	5.92×	0.0%	2	-10.06	3	B
TAOXTAO Synergies Inc.	$2.60	-0.42×	0.55×	40.61×	-0.74×	0.2%	100.0%	-3025.2%	-9609.2%	-131.2%	-37.7%	-52.7%	0×	0.61×	0×	13.99×	2.2%	2	-2.39	2	C+
TLPHTalphera, Inc.	$1.14	-3.35×	2.84×	1,726.72×	-3.41×	-102.6%	100.0%	-48157.1%	-51035.7%	-83.9%	-52.0%	-23.5%	0.38×	-0.04×	0×	5.49×	0.0%	3	-23.57	1	D+
Peer median	—	-1.2×	1.17×	40.61×	-0.74×	-38.6%	100.0%	-3025.2%	-9609.2%	-97.7%	-40.0%	-52.7%	0.03×	0.61×	0×	5.92×	0.0%	2	-3.05	2	—